Heron Therapeutics Inc (HRTX)
3.20
-0.02
(-0.62%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics SG&A Expense (Quarterly): 26.42M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 26.42M |
December 31, 2023 | 23.62M |
September 30, 2023 | 24.60M |
June 30, 2023 | 36.44M |
March 31, 2023 | 36.99M |
December 31, 2022 | 26.70M |
September 30, 2022 | 28.18M |
June 30, 2022 | 32.12M |
March 31, 2022 | 32.96M |
December 31, 2021 | 34.37M |
September 30, 2021 | 34.99M |
June 30, 2021 | 33.16M |
March 31, 2021 | 24.81M |
December 31, 2020 | 28.06M |
September 30, 2020 | 22.00M |
June 30, 2020 | 25.41M |
March 31, 2020 | 30.62M |
December 31, 2019 | 30.29M |
September 30, 2019 | 25.57M |
June 30, 2019 | 33.42M |
March 31, 2019 | 38.37M |
December 31, 2018 | 28.70M |
September 30, 2018 | 23.57M |
June 30, 2018 | 20.74M |
March 31, 2018 | 20.86M |
Date | Value |
---|---|
December 31, 2017 | 22.85M |
September 30, 2017 | 19.99M |
June 30, 2017 | 20.96M |
March 31, 2017 | 18.36M |
December 31, 2016 | 18.54M |
September 30, 2016 | 17.49M |
June 30, 2016 | 15.78M |
March 31, 2016 | 17.22M |
December 31, 2015 | 14.80M |
September 30, 2015 | 8.25M |
June 30, 2015 | 6.839M |
March 31, 2015 | 5.856M |
December 31, 2014 | 5.30M |
September 30, 2014 | 4.222M |
June 30, 2014 | 4.512M |
March 31, 2014 | 5.694M |
December 31, 2013 | 5.477M |
September 30, 2013 | 6.448M |
June 30, 2013 | 4.403M |
March 31, 2013 | 5.612M |
December 31, 2012 | 3.476M |
September 30, 2012 | 2.428M |
June 30, 2012 | 1.313M |
March 31, 2012 | 1.44M |
December 31, 2011 | 1.263M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
22.00M
Minimum
Sep 2020
36.99M
Maximum
Mar 2023
29.54M
Average
29.24M
Median
SG&A Expense (Quarterly) Benchmarks
United Therapeutics Corp | 144.40M |
Ligand Pharmaceuticals Inc | 10.95M |
Esperion Therapeutics Inc | 41.99M |
Aldeyra Therapeutics Inc | 3.210M |
Ionis Pharmaceuticals Inc | 52.64M |